The antiphospholipid antibody dilemma.
Derksen
R H
RH
Department of Internal Medicine, University Hospital Utrecht, The Netherlands.
Hasselaar
P
P
Oosting
J D
JD
De Groot
P G
PG
D000906:Antibodies / Q000502:physiology*; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D011464:Epoprostenol / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D010743:Phospholipids / Q000276:immunology*; D011486:Protein C / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D018179:Receptors, Thrombin; D013917:Thrombin / Q000502:physiology
D000906:Antibodies; D001779:Blood Coagulation Factors; D010743:Phospholipids; D011486:Protein C; D011956:Receptors, Cell Surface; D018179:Receptors, Thrombin; D011464:Epoprostenol; D013917:Thrombin